Icatibant Acetate Injection shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting May 7, 2026 · last update May 7, 2026
Manufacturers: Fresenius Kabi USA, LLC
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Icatibant Acetate, Injection, 10 mg/1 mL (NDC 63323-574-86) | Fresenius Kabi USA, LLC | To Be Discontinued | — | Discontinuation of the manufacturer of the drug | Posted May 7, 2026 Updated May 7, 2026 Discontinued May 7, 2026 |
| Icatibant Acetate, Injection, 10 mg/1 mL (NDC 63323-574-93) | Fresenius Kabi USA, LLC | To Be Discontinued | — | Discontinuation of the manufacturer of the drug | Posted May 7, 2026 Updated May 7, 2026 Discontinued May 7, 2026 |